Mechanism of SOD Action of Mn(II)-Pentaazamacrocycles
J. Phys. Chem. A, Vol. 112, No. 22, 2008 4935
III
+
•-
II
(10) Gonzalez, P. K.; Zhuang, J.; Doctrow, S. R.; Malfroy, B.; Benson,
P. F.; Menconi, M. J.; Fink, M. P. J. Pharmacol. Exp. Ther. 1995, 275,
[
Mn (L)O ] + O f [Mn (L)O ] + O
2 2 2 2
7
98.
3
. Proton-assisted release of the H2O2 with concomitant
(
11) Spasojevi c´ , I.; Batini c´ -Haberle, I.; Stevens, R. D.; Hambright, P.;
conformational relaxation of the Mn(II) complex to yield the
starting compound with pentagonal-bipyramidal coordination
sphere:
Thorpe, A. N.; Grodkowski, J.; Neta, P.; Fridovich, I. Inorg. Chem. 2001,
40, 726.
(
12) Muscoli, C.; Cuzzocrea, S.; Riley, D. P.; Zweier, J. L.; Thiemer-
mann, C.; Wang, Z. Q.; Salvemini, D. Br. J. Pharmacol. 2003, 140, 445.
13) MacMillan-Crow, L. A.; Crow, J. P.; Thompson, J. A. Biochemistry
1998, 37, 1613.
14) Riley, D. P.; Henke, S. L.; Lennon, P. J.; Weiss, R. H.; Neumann,
(
II
+
II
2+
[
Mn (L)O ] + 2H f [Mn (L)] + H O
2 2 2
(
This mechanism supports the view that the catalytic activity
W. L.; Rivers, W. J.; Aston, K. W.; Sample, K. R.; Rahman, H.; Ling,
C. S.; Shieh, J. J.; Busch, D. H.; Szulbinski, W. Inorg. Chem. 1996, 35,
of the Mn(II)-pentaazamacrocyclic complexes is governed
5
213.
(
III
+
by the intermediate geometry of the [Mn (L)O2] and its
reactivity with the second approaching O2•-. In regard to the
folding ability (pentagonal bipyramidal f pseudooctahedral)
15) Aston, K.; Rath, N.; Naik, A.; Slomczynska, U.; Schall, O. F.; Riley,
D. P. Inorg. Chem. 2001, 40, 1779.
16) Riley, D. P.; Lennon, P. J.; Neumann, W. L.; Weiss, R. H. J. Am.
Chem. Soc. 1997, 119, 6522.
17) Riley, D. P.; Rivers, W. J.; Weiss, R. H. Anal. Biochem. 1991,
196, 344.
(18) Salvemini, D.; Wang, Z. Q.; Zweier, J. L.; Samouilov, A.;
(
1
5
as previously proposed, this ligand modification strategy is
still viable, but structural modifications to the initial Mn(II)
complexes should be dictated by the desirable structure of
(
III
+
Macarthur, H.; Misko, T. P.; Currie, M. G.; Cuzzocrea, S.; Sikorski, J. A.;
[
Mn (L)O2] intermediate. As the catalytic activity of the
Riley, D. P. Science 1999, 286, 304.
9
-1 -1
natural enzyme (kcat ∼ 10 M s ) is still unmatched by the
existing SOD mimetics at physiological pH, there is scope for
improvement to be made, possibly by changing the charge
distribution in the ligand and substituent groups to increase its
(
19) Riley, D. P.; Neumann, W. L.; Henke, S. L.; Lennon, P.; Aston,
K. W.; Salvemini, D.; Sikorski, J. A.; Fobian, Y. M.; Grapperhaus, M. L.;
Kusturin, C. L. Substituted pyridino pentaazamacrocycle complexes having
superoxide dismutase activity as therapeutic agents; (Monsanto Company,
USA). US Patent 6214187, 2001.
(20) Anderson, R. F.; Denny, W. A.; Li, W. J.; Packer, J. E.; Tercel,
M.; Wilson, W. R. J. Phys. Chem. A 1997, 101, 9704.
•
-
affinity for O2
.
(
21) Neta, P.; Huie, R. E.; Ross, A. B. J. Phys. Chem. Ref. Data 1988,
Acknowledgment. This work is supported by grant UOA
407 of the Marsden Fund from the Royal Society of New
Zealand.
1
7, 1027.
0
(
22) Klaning, U. K.; Sehested, K. J. Phys. Chem. 1986, 90, 5460.
(23) Bielski, B. H. J.; Allen, A. O. J. Phys. Chem. 1977, 81, 1048.
(
24) Asmus, K.-D.; Janata, E. Conductivity monitoring techniques. In
The study of fast processes and transient species by electron pulse radiolysis;
Baxendale, J. H., Busi, F., Ed.; Reidel: Dordrecht, 1982; pp 91.
References and Notes
(
25) Anderson, R. F.; Shinde, S. S.; Hay, M. P.; Gamage, S. A.; Denny,
W. A. J. Am. Chem. Soc. 2003, 125, 748.
26) Gennett, T.; Milner, D. F.; Weaver, M. J. J. Phys. Chem. 1985,
9, 2787.
27) Meites, L. Handbook of Analytical Chemistry; McGraw Hill: New
York, 1963.
(
1) Halliwell, B.; Gutteridge, J. M. C. Free Radicals in Biology and
Medicine; Oxford University Press: New York, 1999.
(
(
(
2) McCord, J. M. Science 1974, 185, 529.
8
3) Salvemini, D.; Riley, D. P.; Cuzzocrea, S. Nature ReV. Drug
(
DiscoVery 2002, 1, 367.
(
4) Imaizumi, S.; Woolworth, V.; Fishman, R. A.; Chan, P. H. Stroke
990, 21, 1312.
5) Tagaya, M.; Matsumoto, M.; Kitagawa, K.; Niinobe, M.; Ohtsuki,
T.; Hata, R.; Ogawa, S.; Handa, N.; Mikoshiba, K.; Kamada, T. Life Sci.
992, 51, 253.
6) Armstead, W. M.; Mirro, R.; Thelin, O. P.; Shibata, M.; Zuckerman,
S. L.; Shanklin, D. R.; Busija, D. W.; Leffler, C. W. Stroke 1992, 23, 755.
7) Batini c´ -Haberle, I.; Spasojevi c´ , I.; Stevens, R. D.; Hambright, P.;
Fridovich, I. J. Chem. Soc., Dalton Trans. 2002, 2689.
8) Batini c´ -Haberle, I.; Spasojevi c´ , I.; Stevens, R. D.; Hambright, P.;
Neta, P.; Okada-Matsumoto, A.; Fridovich, I. Dalton Trans. 2004, 1696.
9) Batini c´ -Haberle, I.; Spasojevi c´ , I.; Stevens, R. D.; Bondurant, B.;
(
28) McAdam, M. E.; Fox, R. A.; Lavelle, F.; Fielden, E. M. Biochem.
1
J. 1977, 165, 71.
(
(
(
(
29) Riley, D. P.; Weiss, R. H. J. Am. Chem. Soc. 1994, 116, 387.
30) Riley, D. P. Chem. ReV. 1999, 99, 2573.
1
31) Riley, D. P.; Schall, O. F. Structure-activity studies and the design
(
of synthetic superoxide dismutase (SOD) mimetics as therapeutics. In
AdVances in Inorganic Chemistry: Including Bioinorganic Studies; Elsevier:
Amsterdam, 2007; Vol. 59, pp 233.
(
(
32) Dees, A.; Zahl, A.; Puchta, R.; Hommes, N.; Heinemann, F. W.;
Ivanovic-Burmazovic, I. Inorg. Chem. 2007, 46, 2459.
33) Riley, D. P.; Henke, S. L.; Lennon, P. J.; Aston, K. Inorg. Chem.
999, 38, 1908.
(
(
(
1
Okado-Matsumoto, A.; Fridovich, I.; Vujaškovi c´ , Z.; Dewhirst, M. W.
Dalton Trans. 2006, 617.
JP800690U